{
  "ptid_time": "031_S_1209_2009-02-10",
  "img_path": "/data/qiuhui/data/adni/images/031_S_1209/2009-02-10/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 50,377 mm³, 79.5% above the reference mean. With a Z-score of 1.82 (96.6th percentile), this represents moderate enlargement; hippocampal volume measures 5,290 mm³, 25.6% below the reference mean. With a Z-score of -2.35 (0.9th percentile), this represents significant atrophy; whole brain volume measures 1,107,360 mm³, 13.6% above the reference mean. With a Z-score of 1.71 (95.7th percentile), this represents moderate enlargement; entorhinal cortex volume measures 1,955 mm³, 46.8% below the reference mean. With a Z-score of -2.87 (0.2th percentile), this represents significant atrophy; fusiform gyrus volume measures 15,600 mm³, 8.3% below the reference mean. With a Z-score of -0.76 (22.5th percentile), this represents normal volume ; middle temporal gyrus volume measures 20,143 mm³, 5.1% above the reference mean. With a Z-score of 0.44 (67.0th percentile), this represents normal volume . ",
  "text_data": "Age is 74.0 years. Gender is Female. Education: 18 years. MMSE: 25.0. Logical Memory: 0.0. APOEε4 alleles: 1.0. Biomarker levels: Amyloid beta: 585.70 pg/mL (mild reduced); Total tau: 307.30 pg/mL (normal ); Phosphorylated tau: 32.04 pg/mL (mild elevated). ",
  "true_diagnosis": "Diagnosis: AD.",
  "gpt_diagnosis": "**Reasoning:** The imaging data show significant atrophy in the hippocampus and entorhinal cortex, both key regions affected in Alzheimer's disease (AD), along with moderate ventricular enlargement (a marker of neurodegeneration). The clinical profile includes mild cognitive impairment (MMSE 25), APOE4 positivity, mildly reduced Aβ, and mildly elevated p-tau, which are consistent with early AD pathology.  \n\n**Diagnosis:** **MCI (likely due to Alzheimer’s disease)**  \n**Confidence:** **High**",
  "timestamp": "2025-07-26T04:40:50.532572"
}